St. Jude Taking CardioMEMS Message To Payers As Sales Lag Expectations
This article was originally published in The Gray Sheet
Sales of St. Jude Medical's CardioMEMS implantable heart failure monitor are lagging behind the firm's recent predictions. The company cites resistance from payers as the main challenge and executives say they are making a major push to educate insurers about the major cost savings the technology provides.
Register for our free email digests: